Skip to content

GELAPHAR: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

GELAPHAR

BE 0426.709.631
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€65,242
2024 · €60,606+€4,636
Equity
€437,163
2024 · €371,921+€65,242
Cash
€210,146
2024 · €167,984+€42,162
Balance sheet total
€774,089
2024 · €722,807+€51,281

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€44,795

    up €44,795 (+24.7%), from €181,481 to €226,275

  • Cash +€42,162

    up €42,162 (+25.1%), from €167,984 to €210,146

    mainly Net result for the year (+€65,242) and Depreciation (+€34,075)

  • Tangible fixed assets -€30,488

    down €30,488 (-11.3%), from €268,944 to €238,456

    of which Land and buildings: -€29,174

Equity and liabilities
  • Profit (loss) carried forward +€65,242

    up €65,242 (+28.0%), from €233,343 to €298,585

  • Debts after one year -€13,363

    down €13,363 (-45.2%), from €29,574 to €16,211

Income statement
  • Gross operating margin +€60,664

    up €60,664 (+29.2%), from €207,827 to €268,491

  • Staff costs +€55,008

    up €55,008 (+69.5%), from €79,149 to €134,158

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €60,606
Gross operating margin +€60,664
Staff costs -€55,008
Depreciation +€1,201
Other operating charges -€2,055
Financial income +€131
Financial charges +€1,473
Taxes -€1,770
Result 2025 €65,242

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€62,850
Investment -€3,587
Financing -€17,101
Cash 2024 €167,984
Net result for the year +€65,242
Depreciation +€34,075
Stocks and contracts -€44,795
Receivables within one year +€5,277
Deferred charges and accrued income -€90
Trade debts -€1,572
Tax, wage and social debts +€1,480
Other debts +€4,346
Accrued charges and deferred income -€1,114
Investment in fixed assets (net) -€3,587
Debts after one year -€13,363
Current portion of long-term debt -€3,738
Cash 2025 €210,146
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €722,807 €774,089 +€51,281 +7.1%
Fixed assets 21/28 €269,044 €238,556 -€30,488 -11.3%
Tangible fixed assets 22/27 €268,944 €238,456 -€30,488 -11.3%
Land and buildings 22 €264,509 €235,335 -€29,174 -11.0%
Plant, machinery and equipment 23 €850 €642 -€208 -24.5%
Furniture and vehicles 24 €3,585 €2,480 -€1,106 -30.8%
Financial fixed assets 28 €100 €100 = 0.0%
Current assets 29/58 €453,763 €535,533 +€81,769 +18.0%
Stocks and contracts in progress 3 €181,481 €226,275 +€44,795 +24.7%
Stocks 30/36 €181,481 €226,275 +€44,795 +24.7%
Amounts receivable within one year 40/41 €103,935 €98,657 -€5,277 -5.1%
Trade receivables 40 €103,665 €94,103 -€9,562 -9.2%
Other amounts receivable 41 €270 €4,555 +€4,285 +1587.3%
Cash at bank and in hand 54/58 €167,984 €210,146 +€42,162 +25.1%
Deferred charges and accrued income 490/1 €364 €454 +€90 +24.8%
Total equity and liabilities 10/49 €722,807 €774,089 +€51,281 +7.1%
Equity 10/15 €371,921 €437,163 +€65,242 +17.5%
Contributions 10/11 €61,973 €61,973 = 0.0%
Reserves 13 €76,604 €76,604 = 0.0%
Distributable reserves 133 €76,604 €76,604 = 0.0%
Profit (loss) carried forward 14 €233,343 €298,585 +€65,242 +28.0%
Amounts payable 17/49 €350,887 €336,926 -€13,961 -4.0%
Amounts payable after more than one year 17 €29,574 €16,211 -€13,363 -45.2%
Financial debts 170/4 €29,574 €16,211 -€13,363 -45.2%
Amounts payable within one year 42/48 €316,364 €316,879 +€516 +0.2%
Current portion of amounts payable after more than one year 42 €22,174 €18,436 -€3,738 -16.9%
Trade debts 44 €166,587 €165,015 -€1,572 -0.9%
Suppliers 440/4 €166,587 €165,015 -€1,572 -0.9%
Taxes, remuneration and social security 45 €29,903 €31,383 +€1,480 +5.0%
Taxes 450/3 €7,514 €7,128 -€386 -5.1%
Remuneration and social security 454/9 €22,388 €24,255 +€1,866 +8.3%
Other amounts payable 47/48 €97,700 €102,046 +€4,346 +4.4%
Accrued charges and deferred income 492/3 €4,949 €3,835 -€1,114 -22.5%
Remuneration, social security and pensions 62 €79,149 €134,158 +€55,008 +69.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €35,276 €34,075 -€1,201 -3.4%
Other operating charges 640/8 €3,175 €5,231 +€2,055 +64.7%
Gross operating margin 9900 €207,827 €268,491 +€60,664 +29.2%
Operating profit (loss) 9901 €90,227 €95,028 +€4,801 +5.3%
Financial income 75/76B €6 €138 +€131 +2072.1%
Recurring financial income 75 €6 €138 +€131 +2072.1%
Financial charges 65/66B €8,951 €7,478 -€1,473 -16.5%
Recurring financial charges 65 €8,951 €7,478 -€1,473 -16.5%
Profit (loss) for the period before taxes 9903 €81,282 €87,687 +€6,406 +7.9%
Income taxes 67/77 €20,676 €22,445 +€1,770 +8.6%
Profit (loss) for the period 9904 €60,606 €65,242 +€4,636 +7.6%
Profit (loss) for the period to be appropriated 9905 €60,606 €65,242 +€4,636 +7.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.